Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets open in green
Mon, 7 Sep 09:30 am

The major Asian stock markets have opened the day on a mixed note. The stock market in Indonesia and Singapore are down by 1.6% and 0.6% respectively, leading the pack of losers. However stock markets in China and Japan are up by 0.9% and 0.7% respectively.

The major stock indices in the Europe and US ended their previous session in red. The benchmark indices of US ended their previous session lower by 1.06%.The rupee is trading at 66.46 per US dollar.

Indian stock markets have opened the day on an encouraging note. BSE Sensex is trading up by 108 points (up 0.4%) and NSE-Nifty is trading up by 27 points (up 0.4%). Both BSE Mid Cap and BSE Small Cap indices are trading up by 0.5% and 0.52%, respectively. Sectoral indices have opened the day on a mixed note with stocks from banking and automobile sector witnessing buying interest. However stocks from metal and telecommunication sector are witnessing selling pressure.

Major stocks in the pharmaceutical sector have opened the day in green. According to an article in Economic Times, drugmaker Pfizer has been denied patents for certain isomers and stereoisomers by the Indian Patent Office (IPO). The product is used for the treatment of rheumatoid arthritis. The base compound of the drug has been granted patents in India and Pfizer attempted to secure additional patents for the follow up improvements. The article states that the foreign companies are finding it difficult to patent incremental innovations or improvements in the country. Stock of Pfizer is trading up by 0.6%

Major stocks in the automobile sector have opened the day on a positive note. As per an article in leading financial daily, Maruti Suzuki is trying to advance the commencement of Gujarat production facility by three to six months. The Gurgaon and Manesar plant will reach the maximum capacity by the middle of next year. Hence the company is keen to start production from Gujarat from January 2017 instead of May 2017. The construction of the factory building is under way. The first project from Gujarat is expected to be Baleno premium hatchback which is likely to be exported from the western state. The new generations of Swift and Swift Dzire are also likely to be produced at Gujarat facility. Stock of Maruti Suzuki is trading up by 0.6%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets open in green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.